Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
GSK [NYSE]
GlaxoSmithKline plc
Index- P/E14.97 EPS (ttm)3.16 Insider Own- Shs Outstand2.41B Perf Week0.77%
Market Cap114.14B Forward P/E13.93 EPS next Y3.40 Insider Trans- Shs Float2.42B Perf Month-0.13%
Income7.73B PEG4.04 EPS next Q- Inst Own11.20% Short Float0.50% Perf Quarter-13.12%
Sales40.35B P/S2.83 EPS this Y22.60% Inst Trans5.22% Short Ratio3.37 Perf Half Y-11.44%
Book/sh4.18 P/B11.31 EPS next Y5.43% ROA16.70% Target Price55.67 Perf Year-4.31%
Cash/sh2.20 P/C21.50 EPS next 5Y3.70% ROE105.20% 52W Range46.01 - 55.95 Perf YTD-9.20%
Dividend2.59 P/FCF137.67 EPS past 5Y4.70% ROI24.90% 52W High-14.90% Beta0.60
Dividend %5.48% Quick Ratio0.80 Sales past 5Y1.70% Gross Margin68.90% 52W Low3.48% ATR0.53
Employees99451 Current Ratio1.10 Sales Q/Q-16.00% Oper. Margin24.90% RSI (14)47.54 Volatility0.80% 0.81%
OptionableYes Debt/Eq2.88 EPS Q/Q-37.10% Profit Margin27.60% Rel Volume2.15 Prev Close47.29
ShortableYes LT Debt/Eq2.37 EarningsFeb 03 Payout69.30% Avg Volume3.57M Price47.61
Recom2.60 SMA20-0.27% SMA50-2.46% SMA200-8.54% Volume4,881,805 Change0.68%
08-Aug-14Reiterated Argus Buy $65 → $55
23-Apr-14Upgrade Argus Hold → Buy
28-May-13Upgrade Deutsche Bank Hold → Buy
11-Jan-11Upgrade Jefferies Hold → Buy
02-Jun-10Upgrade Jefferies Hold → Buy
16-Feb-10Upgrade JP Morgan Underweight → Neutral $26
13-Jan-10Downgrade Credit Suisse Outperform → Underperform
24-Nov-09Initiated Leerink Swann Mkt Perform
16-Nov-09Initiated Deutsche Securities Hold
12-Nov-09Initiated Barclays Capital Equal Weight
23-Oct-09Downgrade Jefferies & Co Buy → Hold
17-Mar-09Initiated Credit Suisse Outperform
26-Jan-09Initiated Jefferies & Co Buy
14-Nov-08Downgrade UBS Buy → Neutral
18-Apr-08Downgrade JP Morgan Neutral → Underweight
11-Feb-08Upgrade UBS Neutral → Buy
01-Feb-08Upgrade HSBC Securities Underweight → Neutral
24-Oct-07Initiated Bernstein Mkt Perform
06-Sep-07Initiated UBS Neutral
25-Jul-07Downgrade Bear Stearns Peer Perform → Underperform
19-Sep-14 12:27PM  How Will GlaxoSmithKline (GSK) Stock Be Affected By This Lawsuit? at TheStreet
11:39AM  China fines GlaxoSmithKline $492M for bribery AP
11:39AM  China fines GlaxoSmithKline $492M for bribery AP
10:58AM  Glaxo Faces an Uphill Battle in China at The Wall Street Journal
10:20AM  Glaxo Found Guilty of Bribery in China: Can Witty Rehabilitate the Drug Maker? at The Wall Street Journal
09:45AM  Glaxo Found Guilty of Bribery in China: Can Witty Rehabilitate the Drug Maker? at The Wall Street Journal
08:58AM  [$$] Glaxo Guilty of Bribery in China at The Wall Street Journal
08:21AM  [$$] Glaxo Is Guilty of Bribery in China at The Wall Street Journal
06:37AM  What Alibaba means to China CNBC
06:19AM  U.S. stocks: Futures higher as Fed rate view holds at MarketWatch
05:54AM  GlaxoSmithKline convicted of bribery in China, ordered to pay half billion fine at CNNMoney.com
05:33AM  [$$] Glaxo Found Guilty of Bribery in China at The Wall Street Journal
05:12AM  China fines GSK $492M, jails managers for bribery at USA TODAY
05:06AM  China Fines GlaxoSmithKline Nearly $500 Million in Bribery Case at New York Times
04:17AM  China Fines Glaxo $489 Million, Ending Bribery Probe at Bloomberg
18-Sep-14 04:52PM  FDA Approves Lilly's Once-Weekly Shot For Diabetes at Forbes
03:00AM  Europe shares open higher on Fed relief CNBC
17-Sep-14 05:00PM  Five Prime Therapeutics' Novel Target Licensed by Glaxo Zacks
16-Sep-14 06:00PM  Cramer: Selling ahead of Alibaba IPO over CNBC
06:35AM  Ebola under the microscope CNBC
15-Sep-14 04:35PM  Novartis Presents Positive Data on Lucentis and Jetrea Zacks
10-Sep-14 12:22PM  Gates Foundation Commits $50 Million To Ebola Containment Efforts at Forbes
09:36AM  Trade Ebola Stocks? Sure, But Don't Bet on Big Business Opportunity at TheStreet
08:23AM  The Zacks Analyst Blog Highlights: Lloyds Banking Group, Royal Bank of Scotland Group, BHP Billiton, HSBC Holdings and GlaxoSmithKline Zacks
09-Sep-14 05:20PM  Glaxo (GSK) Updates on Asthma Candidate Mepolizumab Zacks
10:18AM  Glaxo Consumer Health Unit is Linked to a US Probe In 2012 at The Wall Street Journal
10:10AM  Scottish Vote Ahead: Dump These 3 Stocks Zacks
08:17AM  Why GlaxoSmithKline (GSK) Stock Is Falling Today at TheStreet
08-Sep-14 04:25PM  Glaxo Announces EU Nod for Single-Pill HIV Drug Triumeq Zacks
04:05PM  Novartis (NVS) Presents Positive Data on Ultibro Breezhaler Zacks
09:07AM  Stock Futures Down, But Not Far; Alibaba Sets IPO Price Range at Investor's Business Daily
05-Sep-14 03:01PM  WHO Ebola Drug Panel: Use Survivor Serum To Treat Ebola Victims at Forbes
04-Sep-14 04:03PM  FDA Approves Merck's PD-1 Inhibitor, Keytruda at Forbes
02:37PM  J&J Ebola Vaccine Gets Funding, Development to Pick Pace Zacks
02-Sep-14 02:40PM  Glaxo Up on Accelerated Ebola Vaccine Development Process Zacks
02:08PM  BioCryst's Ebola Candidate Moving to Efficacy Study Soon Zacks
29-Aug-14 11:01AM  [video] Human trials of Ebola Vaccine at CNBC
28-Aug-14 05:23PM  [video] Human Trials of an Ebola Vaccine Launch at MarketWatch
01:52PM  [video] Ebola response roadmap at CNBC
12:45PM  [video] GlaxoSmithKline Ebola Vaccine Being Fast-Tracked for Human Trials at TheStreet
12:26PM  Use caution when investing in Ebola-related stocks at MarketWatch
12:18PM  [video] Stocks Weighed by Ukraine Crisis Overtaking Positive Economic Data at TheStreet
11:19AM  JPMorgan hit by hackers, GlaxoSmithKline ebola vaccine coming, Abercrombie getting waxed Yahoo Finance
10:32AM  Why GlaxoSmithKline (GSK) Stock Is Gaining Today at TheStreet
08:55AM  GSK & NIAID Ebola Vaccine To Enter UK Human Safety Trials; Broad International Collaboration at Forbes
07:58AM  Early movers: ANF, DG, GS, JPM, C, GSK, WSM & more at CNBC
27-Aug-14 04:00PM  Glaxo's Promacta Label Now Includes Severe Aplastic Anemia Zacks
11:30AM  Top 3 Yielding Buy-Rated Stocks: PAA, VZ, GSK at TheStreet
26-Aug-14 03:52PM  GSK receives FDA approval of an additional Promacta® (eltrombopag) indication for use in patients with severe aplastic anaemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST) PR Newswire
01:00PM  4 Foreign Blue-Chip Stocks With 4% Dividend Yields to Buy at TheStreet
08:26AM  The Zacks Analyst Blog Highlights: GlaxoSmithKline, Pfizer, Johnson & Johnson, Allergan and EA Sports Zacks
25-Aug-14 03:30PM  ViiV Healthcare's Single-Pill HIV Drug Triumeq Cleared by FDA Zacks
12:10PM  [video] Jim Cramer Says Roche's "Bolt-On" Acquisition Means Big Pharma is Thinking Big at TheStreet
11:40AM  InterMune Stock Spikes On Rare Big Biotech Buyout at Investor's Business Daily
09:00AM  Multimedia assets now available: ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection PR Newswire
22-Aug-14 03:46PM  ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection PR Newswire
21-Aug-14 04:05PM  GlaxoSmithKline's (GSK) Arnuity Ellipta Approved by FDA Zacks
07:49AM  The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International Zacks
20-Aug-14 03:33PM  GSK receives FDA approval for Arnuity Ellipta® (fluticasone furoate) in the US for the treatment of asthma PR Newswire
03:01PM  Why Mylan (MYL) Stock Is Advancing Today at TheStreet
06:01AM  Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win at TheStreet
19-Aug-14 10:11AM  The Warren Buffett Guide to Making Money Yahoo Finance Blogs
18-Aug-14 09:09AM  As The Ebola Outbreak Expands, These Experimental Drugs Could See Action at Forbes
09:09AM  As Ebola Outbreak Expands, These Experimental Drugs Could See Action at Forbes
12-Aug-14 03:56PM  [$$] Glaxo's Chief Faces Rising Pressure at The Wall Street Journal
12:37PM  [$$] Glaxo's Chief Faces Rising Pressure at The Wall Street Journal
09:50AM  Moving Average Crossover Alert: GlaxoSmithKline (GSK) Zacks
09:49AM  How Will GlaxoSmithKline (GSK) Stock React To Multiple Pressures Facing The Drug Maker? at TheStreet
12:17AM  [$$] Glaxo's Chief Faces Rising Pressure at The Wall Street Journal
11-Aug-14 10:51PM  [$$] Glaxo's Chief Faces Rising Pressure at The Wall Street Journal
09:24PM  [$$] Glaxo's Chief Faces Rising Pressure at The Wall Street Journal
05:30PM  [video] Biotechs race for Ebola cure at CNBC
05:15PM  [$$] Glaxo Chief Faces Rising Pressure at The Wall Street Journal
01:30PM  How Will GlaxoSmithKilne (GSK) Stock Respond To New Drug Bribery Allegations In Syria? at TheStreet
09:56AM  [video] U.S. Markets Start Week Higher On Easing Geopolitical Tensions at TheStreet
09:09AM  Priceline's outlook disappoints; Kinder Morgan unites; MannKind shares rocket Hot Stock Minute
07:59AM  Amazon picks a new fight; The bulls are back; Debate over experimental Ebola drugs Hot Stock Minute
07:59AM  Amazon picks a new fight; The bulls are back; Debate over experimental ebola drugs Hot Stock Minute
07:59AM  Amazon picks a new fight; China increases pressure on foreign companies; Debate over experimental Ebola drugs Hot Stock Minute
06:58AM  Super Moon illusion or buy the dips on this stock market? at MarketWatch
08-Aug-14 04:10PM  Dynavax Technologies Q2 Loss Wider than Expected, Sales Beat Zacks
11:58AM  In China, British Investigator Hired by Glaxo, and Wife, Sentenced to Prison at New York Times
11:58AM  In China, British Investigator Hired by Glaxo, and His Wife, Are Sentenced to Prison at New York Times
11:58AM  In China, British Investigator Hired by Glaxo and His Wife Are Sentenced to Prison at New York Times
08:10AM  Theravance (THRX) Incurs Narrower-than-Expected Loss in Q2 Zacks
06:43AM  [video] Glaxo trial begins in China at CNBC
05-Aug-14 05:22PM  Drugmaker AstraZeneca Returns To Growth at Investor's Business Daily
04:24PM  Glaxos Advair Win Undermined by Lack of Coverage on Breo Drug at Bloomberg
09:00AM  GSK's COPD.com Relaunch Promotes Understanding and Dialogue about COPD PR Newswire
06:45AM  Chinese Regulators Search Daimler Offices at New York Times
06:45AM  Chinese Regulators Search Daimler Offices at New York Times
04-Aug-14 07:01PM  Novo Nordisk Leapfrogs Glaxo as U.K. Drug Giant Declines at Bloomberg
04:18PM  Stock Market Today: Risky Complacency Brings Stocks Higher TheStreet
03:39PM  Stock Market Today: Risky Complacency Brings Stocks Higher TheStreet
11:03AM  Why GlaxoSmithKline (GSK) Stock Is Higher Today at TheStreet
03-Aug-14 11:04AM  Rising China's Hidden Edge: 'Flexible' Law Enforcement at Forbes
01-Aug-14 08:47AM  GlaxoSmithKline LLC -- Moody's downgrades GlaxoSmithKline to A2, outlook stable at Moody's
31-Jul-14 11:35AM  [video] Catalent Pharma Solutions CEO Talks IPO, Potential Biotech Bubble at TheStreet
30-Jul-14 06:00PM  Why There's Far More To Pfizer Than Viagra at Investopedia
05:20AM  AstraZeneca to Pay Up to $2.1 Billion For Respiratory Drugs at New York Times
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, such as vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company provides pharmaceutical products in various therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also offers consumer health products in total wellness, oral care, nutritional, and skin health areas. The company's total wellness products comprise Panadol for the treatment of headache and joint pain, fever, and cold symptoms; NicoDerm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to quitting smoking; and ENO Tums, a rapid relief antacid. Its oral care products include Sensodyne for the prevention of dental sensitivity; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; Aquafresh for the prevention of caries, gum disease, and bad breath; and Parodontax to help stop bleeding gums and gum health. The company's nutrition products comprise Horlicks and Maxinutrition for nutrition; and skin health products include Physiogel, a face and body care product for dry, sensitive, and irritated skin, and Oilatum, a soothing treatment for eczema and dry skin conditions. In addition, it provides prescription medicines; and paediatric and adult vaccines against various infectious diseases. The company has a strategic cancer immunotherapy collaboration with Adaptimmune Limited to develop and commercialize NY-ESO-1 clinical cancer program. GlaxoSmithKline plc was founded in 1935 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLC10% OwnerAug 11Buy3912271.66172,651675,457,614,37130,748,723Aug 11 04:55 PM
GLAXOSMITHKLINE PLC10% OwnerMay 09Buy8544835.30317,7702,715,292,313,28130,576,072May 13 04:43 PM
GLAXOSMITHKLINE PLC10% OwnerApr 01Buy12.00103,7621,245,1441,989,598Apr 02 12:42 PM
GLAXOSMITHKLINE PLCFormer 10% OwnerFeb 19Buy14.0035,000490,0001,356,533Feb 20 06:56 PM
GLAXOSMITHKLINE PLC10% OwnerFeb 11Buy12850698.95342,2294,397,881,850,96030,258,302Feb 13 04:41 PM
GLAXOSMITHKLINE PLCFormer 10% ShareholderFeb 10Buy12.00143,7731,725,276143,773Feb 12 05:56 PM
GLAXOSMITHKLINE PLC10% OwnerOct 29Buy4913613.18130,473641,093,852,43429,916,073Oct 29 05:37 PM